2022
DOI: 10.1536/ihj.21-821
|View full text |Cite
|
Sign up to set email alerts
|

Successful Mitral Valve Replacement in an Infant with Neonatal Marfan Syndrome due to a Novel Missense Mutation of the <i>FBN1</i> Gene

Abstract: Marfan syndrome is an autosomal dominant genetic disorder of the fibrous connective tissue caused by pathogenic mutations in the fibrillin-1 gene. Neonatal Marfan syndrome is a rare type of Marfan syndrome that is genotypically and phenotypically different from classical Marfan syndrome and has a poor prognosis. Most patients with neonatal Marfan syndrome die during infancy due to severe and rapidly progressive cardiovascular disorders. Here, we present a case of an 11-year-old girl with neonatal Marfan syndro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 25 publications
0
3
0
Order By: Relevance
“…[15][16][17] FBN1 gene encodes for FBN1, an extracellular matrix protein, which is an essential structural macromolecule that polymerizes into microfibrils. FBN1 gene has been identified as the primary disease-associated gene of MFS, 18,19 as well as variants in latent transforming growth factor-β (TGF-β) binding proteins (LTBPs). 20 Mutations in FBN1 gene have also been found to cause isolated EL without systemic diseases.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…[15][16][17] FBN1 gene encodes for FBN1, an extracellular matrix protein, which is an essential structural macromolecule that polymerizes into microfibrils. FBN1 gene has been identified as the primary disease-associated gene of MFS, 18,19 as well as variants in latent transforming growth factor-β (TGF-β) binding proteins (LTBPs). 20 Mutations in FBN1 gene have also been found to cause isolated EL without systemic diseases.…”
Section: Discussionmentioning
confidence: 99%
“…According to the Ghent criteria, EL patients are diagnosed with MFS if they have aortic dilatation, a family history of MFS, or sufficient minor findings 15 . Of EL patients, 57/123 (46.3%) with FBN1 gene mutations were classified as MFS in a retrospective study 19 . Therefore, regular cardiovascular follow-up is recommended for patients with EL 53 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation